Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery

Neogenix, LLC dba Ogenix

Overview

EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).

Anorectal procedures more often lead to surgical site infections. Such infections are unfortunately frequent and can be difficult for the patient and the treating physician. Wound hypoxia has been identified as a pathogenic mechanism behind wound infection and poor healing. Transdermal oxygen delivery (EPIFLO) is intended to promote the healing process in chronic wounds as an adjunct to standard wound care in wound management and treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Conditions

Anorectal Surgeries

Interventions

EpifloDEVICE

Transdermal continuous oxygen therapy is oxygen delivery to the wound site directly. Ogenix makes a small portable oxygen concentrator (Trade Name: EPIFLO) that makes continuous transdermal delivery of oxygen possible. It is a 3 ounce oxygen generator that continuously delivers 3 ml of pure oxygen to the wound site.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Elective colo-rectal surgery with or without anastomosis and with or without stoma * Patient age: 18-80 Exclusion Criteria: * Pregnancy * Anesthesiology ASA score of 4 or above * fever or existing signs of infection at the time of surgery * Diabetes Mellitus type I or II with HbA1C level 12% or more * Persons with decubitus or diabetic ulcers * Subjects with peritoneal metastases * Patients with severe malnutrition as indicated by Prealbumin value of \<20 * BMI ≥50

Locations (1)

Department of General Surgery Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Outcomes

Primary Outcomes

Number of patients with surgical site infections measured with the Southampton Scoring System. The number of subjects with infection of the surgical site will be compared using chi-square or Fisher Exact test.

The primary objective of this study is to assess surgical site infection within 30 days of surgery for "high risk" patients undergoing colo-rectal surgery in patients receiving adjunct Transdermal Continuous Oxygen therapy vs. standard of care control Measures as either yes infection or no infection

Time frame: 30 days

Secondary Outcomes

Severity of infection measured with the Southampton Scoring System

Severity of infection using Southampton Scoring System. To maintain the trial-wise Type I error rate at 0.05, a closed test procedure will be used for the secondary endpoints

Time frame: 30 days

Number of days until patients surgical site is healed

Time to heal. To maintain the trial-wise Type I error rate at 0.05, a closed test procedure will be used for the secondary endpoints

Time frame: 30 days

Resource utilization - cost of treatments, hospital stays, bandages, nursing care

Resource utilization - cost of treatments, hospital stays, bandages, nursing care all measured in dollar amounts and then summed

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.